Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer

[1]  P. Belleau,et al.  Protein diversity is generated within the motin family of proteins by alternative pre-mRNA splicing. , 2005, Gene.

[2]  G. Watkins,et al.  Assessing microvessels and angiogenesis in human breast cancer, using VE‐cadherin , 2005, Histopathology.

[3]  G. Watkins,et al.  Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. , 2004, European journal of cancer.

[4]  G. Watkins,et al.  Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. , 2004, Endocrine-related cancer.

[5]  R. Mansel,et al.  Expression of peroxisome‐proliferator activated receptor‐gamma (PPARγ) and the PPARγ co‐activator, PGC‐1, in human breast cancer correlates with clinical outcomes , 2003 .

[6]  G. Watkins,et al.  Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  T. Nakamura,et al.  Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist. , 2003, Carcinogenesis.

[8]  R. Behringer,et al.  Angiomotin Regulates Visceral Endoderm Movements during Mouse Embryogenesis , 2003, Current Biology.

[9]  J. Sloane,et al.  Angiogenesis and invasive recurrence in ductal carcinoma in situ of the breast. , 2003, European journal of cancer.

[10]  Erwin G. Van Meir,et al.  Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. , 2002, Gene.

[11]  Lois E. H. Smith,et al.  Molecular profiling of angiogenesis markers. , 2002, The American journal of pathology.

[12]  H. DeLisser,et al.  Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. , 2002, American journal of physiology. Cell physiology.

[13]  Y. Ono,et al.  JEAP, a Novel Component of Tight Junctions in Exocrine Cells* , 2002, The Journal of Biological Chemistry.

[14]  P. Bryant,et al.  Altered Expression and Localization of the Tight Junction Protein ZO-1 in Primary and Metastatic Pancreatic Cancer , 2001, Pancreas.

[15]  Shoichiro Tsukita,et al.  Multifunctional strands in tight junctions , 2001, Nature Reviews Molecular Cell Biology.

[16]  L. Holmgren,et al.  Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. , 2001, The Journal of cell biology.

[17]  I. Fidler,et al.  Critical determinants of cancer metastasis: rationale for therapy , 1999, Cancer Chemotherapy and Pharmacology.

[18]  P. Bryant,et al.  Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. , 1998, The American journal of pathology.

[19]  I. Nazarenko,et al.  A closed tube format for amplification and detection of DNA based on energy transfer. , 1997, Nucleic acids research.

[20]  M. Mori,et al.  Enhanced paracellular barrier function of rat mesothelial cells partially protects against cancer cell penetration. , 1996, British Journal of Cancer.

[21]  K. Alitalo,et al.  Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis. , 1996, British Journal of Cancer.

[22]  M. Saitoh,et al.  Localization of 7H6 tight junction-associated antigen along the cell border of vascular endothelial cells correlates with paracellular barrier function against ions, large molecules, and cancer cells. , 1996, Experimental cell research.

[23]  A. Harris,et al.  Mechanisms and therapeutic implications of angiogenesis. , 1996, Current opinion in oncology.

[24]  W. Aird,et al.  Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  W. Jiang,et al.  Molecular and cellular basis of cancer invasion and metastasis: Implications for treatment , 1994, The British journal of surgery.

[26]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[27]  A. Harris,et al.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer , 1992, The Lancet.

[28]  M. Lampugnani,et al.  A novel endothelial-specific membrane protein is a marker of cell-cell contacts , 1992, The Journal of cell biology.

[29]  J. Folkman.  Angiogenesis--retrospect and outlook. , 1992, EXS.